ArabFinance:  Financial Regulatory Authority approved publishing Rameda Pharmaceutical's prospectus for offering 376,606,000 shares, representing 60% of total share capital, in the secondary market. The company will sell its shares at EGP 4.66 per share, however, the fair value of Rameda's share is amounting to EGP 6.67/share, according to the Independent Financial Advisor (IFA).

The company shares will be offering into two tranches; Public offering and Private Offering, as follows: 

- It offers 18,830,300 shares in Public Offering, representing 5% of the offered shares

- It offers 357,775,700 shares in the Private offering for institutions, which represents 95% of the offered shares and 55.59% of total company share capital. 

It is worth mentioning that the stock will be trading starting from December 11, 2019. 

Misr For Central Clearing sets refunding date for money spared under account of Rameda's IPO Updated 12/5/2019 12:09:44 PM

EGX oks listing shares of Rameda Pharmaceutical's capital increase Updated 12/5/2019 4:34:01 PM

Rameda's profits drop to EGP 31M ending Sept. 2019 Updated 12/4/2019 4:50:57 PM

Rameda Pharmaceutical's share placement covered 1.17 times Updated 12/4/2019 5:04:00 PM